These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 28701473)

  • 1. Zbtb7a induction in alveolar macrophages is implicated in anti-HLA-mediated lung allograft rejection.
    Nayak DK; Zhou F; Xu M; Huang J; Tsuji M; Yu J; Hachem R; Gelman AE; Bremner RM; Smith MA; Mohanakumar T
    Sci Transl Med; 2017 Jul; 9(398):. PubMed ID: 28701473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Term Persistence of Donor Alveolar Macrophages in Human Lung Transplant Recipients That Influences Donor-Specific Immune Responses.
    Nayak DK; Zhou F; Xu M; Huang J; Tsuji M; Hachem R; Mohanakumar T
    Am J Transplant; 2016 Aug; 16(8):2300-11. PubMed ID: 27062199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel mechanism for immune regulation after human lung transplantation.
    Mohanakumar T; Sharma M; Bansal S; Ravichandran R; Smith MA; Bremner RM
    J Thorac Cardiovasc Surg; 2019 May; 157(5):2096-2106. PubMed ID: 31288367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interplay between immune responses to HLA and non-HLA self-antigens in allograft rejection.
    Angaswamy N; Tiriveedhi V; Sarma NJ; Subramanian V; Klein C; Wellen J; Shenoy S; Chapman WC; Mohanakumar T
    Hum Immunol; 2013 Nov; 74(11):1478-85. PubMed ID: 23876679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donor-specific antibodies are associated with antibody-mediated rejection, acute cellular rejection, bronchiolitis obliterans syndrome, and cystic fibrosis after lung transplantation.
    Lobo LJ; Aris RM; Schmitz J; Neuringer IP
    J Heart Lung Transplant; 2013 Jan; 32(1):70-7. PubMed ID: 23260706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of donor-derived exosomes in lung allograft rejection.
    Ravichandran R; Bansal S; Rahman M; Sharma M; Liu W; Bharat A; Hachem R; Omar A; Smith MA; Mohanakumar T
    Hum Immunol; 2019 Aug; 80(8):588-594. PubMed ID: 30898684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De Novo DQ Donor-Specific Antibodies Are Associated with Chronic Lung Allograft Dysfunction after Lung Transplantation.
    Tikkanen JM; Singer LG; Kim SJ; Li Y; Binnie M; Chaparro C; Chow CW; Martinu T; Azad S; Keshavjee S; Tinckam K
    Am J Respir Crit Care Med; 2016 Sep; 194(5):596-606. PubMed ID: 26967790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of miRNA-155 in the immunopathogenesis of obliterative airway disease in mice induced by circulating exosomes from human lung transplant recipients with chronic lung allograft dysfunction.
    Bansal S; Itabashi Y; Perincheri S; Poulson C; Bharat A; Smith MA; Bremner RM; Mohanakumar T
    Cell Immunol; 2020 Sep; 355():104172. PubMed ID: 32707293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of class II major histocompatibility complex antigens (HLA-DR) and lymphocyte subset immunotyping in chronic pulmonary transplant rejection.
    Hasegawa S; Ockner DM; Ritter JH; Patterson GA; Trulock EP; Cooper JD; Wick MR
    Arch Pathol Lab Med; 1995 May; 119(5):432-9. PubMed ID: 7748071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune Responses to Tissue-Restricted Nonmajor Histocompatibility Complex Antigens in Allograft Rejection.
    Bharat A; Mohanakumar T
    J Immunol Res; 2017; 2017():6312514. PubMed ID: 28164137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bronchiolitis obliterans syndrome due to donor-specific HLA-antibodies.
    Kauke T; Kneidinger N; Martin B; Dick A; Schneider C; Schramm R; Meimarakis G; Preissler G; Eickelberg O; von Dossow V; Behr J; Hatz R; Neurohr C; Winter H
    Tissue Antigens; 2015 Sep; 86(3):178-85. PubMed ID: 26204790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alloimmunity-induced autoimmunity as a potential mechanism in the pathogenesis of chronic rejection of human lung allografts.
    Saini D; Weber J; Ramachandran S; Phelan D; Tiriveedhi V; Liu M; Steward N; Aloush A; Hachem R; Trulock E; Meyers B; Patterson GA; Mohanakumar T
    J Heart Lung Transplant; 2011 Jun; 30(6):624-31. PubMed ID: 21414808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating Exosomes with Distinct Properties during Chronic Lung Allograft Rejection.
    Gunasekaran M; Sharma M; Hachem R; Bremner R; Smith MA; Mohanakumar T
    J Immunol; 2018 Apr; 200(8):2535-2541. PubMed ID: 29491008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement activation is not required for obliterative airway disease induced by antibodies to major histocompatibility complex class I: Implications for chronic lung rejection.
    Takenaka M; Subramanian V; Tiriveedhi V; Phelan D; Hachem R; Trulock E; Gelman AE; Patterson GA; Hoshinaga K; Mohanakumar T
    J Heart Lung Transplant; 2012 Nov; 31(11):1214-22. PubMed ID: 22980951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decline in Club Cell Secretory Proteins, Exosomes Induction and Immune Responses to Lung Self-antigens, Kα1 Tubulin and Collagen V, Leading to Chronic Rejection After Human Lung Transplantation.
    Itabashi Y; Ravichandran R; Bansal S; Bharat A; Hachem R; Bremner R; Smith M; Mohanakumar T
    Transplantation; 2021 Jun; 105(6):1337-1346. PubMed ID: 32890135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement-Activating Anti-HLA Antibodies in Kidney Transplantation: Allograft Gene Expression Profiling and Response to Treatment.
    Lefaucheur C; Viglietti D; Hidalgo LG; Ratner LE; Bagnasco SM; Batal I; Aubert O; Orandi BJ; Oppenheimer F; Bestard O; Rigotti P; Reisaeter AV; Kamar N; Lebranchu Y; Duong Van Huyen JP; Bruneval P; Glotz D; Legendre C; Empana JP; Jouven X; Segev DL; Montgomery RA; Zeevi A; Halloran PF; Loupy A
    J Am Soc Nephrol; 2018 Feb; 29(2):620-635. PubMed ID: 29042454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-HLA antibody binding to hla class I molecules induces proliferation of airway epithelial cells: a potential mechanism for bronchiolitis obliterans syndrome.
    Reznik SI; Jaramillo A; Zhang L; Patterson GA; Cooper JD; Mohanakumar T
    J Thorac Cardiovasc Surg; 2000 Jan; 119(1):39-45. PubMed ID: 10612759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of antibodies to lung self-antigens (Kα1 tubulin and collagen V) and donor specific antibodies to HLA in lung transplant recipients and implications for lung transplant outcomes: Single center experience.
    Rao U; Sharma M; Mohanakumar T; Ahn C; Gao A; Kaza V
    Transpl Immunol; 2019 Jun; 54():65-72. PubMed ID: 30794945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-human leukocyte antigen antibodies and preemptive antibody-directed therapy after lung transplantation.
    Hachem RR; Yusen RD; Meyers BF; Aloush AA; Mohanakumar T; Patterson GA; Trulock EP
    J Heart Lung Transplant; 2010 Sep; 29(9):973-80. PubMed ID: 20558084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of non-HLA antibodies on outcomes after lung transplantation and implications for therapeutic approaches.
    Hachem RR
    Hum Immunol; 2019 Aug; 80(8):583-587. PubMed ID: 31005400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.